探索身体质量指数对瘤生物学和癌症发展的影响
Johanne Ahrenfeldt1,2, Stine Carstensen2, Ida Maria Hemdorff Eriksen2
1Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Journal of cancer research and clinical oncology
|July 27, 2024
概括
肥胖与癌症患者的较小,较少侵入性瘤,具有明显的基因表达和较高的免疫活性有关. 这些发现表明,肥胖影响瘤生物学,影响个性化治疗方法.
科学领域:
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
- 免疫学 免疫学 免疫学
背景情况:
- 肥胖与癌症风险和患者的结果存在复杂的关系,被称为"肥胖悖论".
- 了解肥胖对瘤生物学的影响对于推进癌症治疗至关重要.
研究的目的:
- 研究肥胖如何影响瘤特征,包括基因表达,通路功能障碍,遗传变化和免疫透.
- 为了分析10种癌症类型的1781名患者的队列.
主要方法:
- 利用了来自癌症基因组图谱 (TCGA) 的数据.
- 分析患者的注释,包括体重指数 (BMI),年龄,性别,瘤大小和基因表达.
- 肥胖和非肥胖患者组之间的瘤特征比较.
主要成果:
- 与非肥胖患者 (T3-T4) 相比,肥胖患者呈现较小,侵入性较小的瘤 (T1-T2).
- 在肥胖患者中观察到不同的基因表达特征,特别是在代谢和增殖途径中.
- 肥胖患者的瘤显示免疫细胞透和T细胞多样性增加,表明免疫活性增强.
结论:
- 肥胖显著影响瘤生物学,影响瘤大小,侵入性,基因表达和免疫微环境.
- 研究结果表明,需要个性化治疗策略,以整合患者生理和瘤特征.
- 对肥胖悖论的进一步研究可能会揭示新的治疗点.
相关概念视频
Obesity
418
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
418
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer
48.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


